A5043353916- Vaccine Coverage and Hesitancy
- COVID-19 epidemiological studies
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Zoonotic diseases and public health
- Animal Disease Management and Epidemiology
- Health Policy Implementation Science
- COVID-19 and Mental Health
- Pneumonia and Respiratory Infections
- Child Nutrition and Water Access
- Child and Adolescent Health
- Diabetes Management and Education
- Community Health and Development
- Primary Care and Health Outcomes
- Global Health and Epidemiology
- Bacterial Infections and Vaccines
- Global Maternal and Child Health
- Hepatitis B Virus Studies
- Hepatitis C virus research
- Viral gastroenteritis research and epidemiology
- Pharmaceutical Economics and Policy
- Viral Infections and Outbreaks Research
- Hepatitis Viruses Studies and Epidemiology
- Fisheries and Aquaculture Studies
- Innovation and Socioeconomic Development
University of Indonesia
2019-2024
Ministry of Health
2024
Australian National University
2022-2023
Global Fund to Fight AIDS, Tuberculosis and Malaria
2007
Objective This qualitative study explored the current barriers and enablers of diabetes care in Indian Ocean Territories (IOT). Methods A constructivist grounded theory approach that incorporated semi-structured telephone interviews was employed. Initial analysis interview transcripts used a line-by-line approach, to identify recurring themes, connections, patterns, before they were re-labelled categorised. followed by axial coding, categorisation refinement, mapping triggers IOT....
Objectives Co-creation of diabetes and obesity prevention with remote communities allows local contextual factors to be included in the design, delivery, evaluation disease efforts. The Indian Ocean Territories (IOT) comprise Christmas (CI) Cocos Keeling Islands (CKI) are Australian external territories located northwest mainland. We present results a co-design process conducted residents IOT using realist inquiry system mapping. Methods Interviews 33 community members (17 CI, 14 CKI, 2 off...
Continued efforts to reduce the burden of COVID-19 require consideration additional booster doses and emerging oral antivirals. This study explored individual- population-level impacts dose antivirals in Indonesia, Fiji, Papua New Guinea, Timor-Leste. Our mathematical model included age structure, vaccine coverage, prevalence comorbidities, immunity from prior infection fit incidence data our settings. We a range eligibility criteria found that boosters had largest impact per when...
Abstract Background COVID-19 vaccine coverage in low- and middle-income countries continues to be challenging. As supplies increase, is increasingly becoming determined by rollout capacity. Methods We developed a deterministic compartmental model of transmission explore how age-, risk-, dose-specific prioritisation strategies can minimise severe outcomes Sierra Leone. Results Prioritising booster doses older adults with comorbidities could reduce the incidence disease 23% deaths 34% compared...
Globally, there has been a commitment to produce and distribute vaccine within 100 days of the next pandemic. This 100-day target will place pressure on countries make swift decisions how optimise delivery. We used data from COVID-19 pandemic inform mathematical modelling future pandemics in Indonesia for wide range characteristics. explored benefits vaccination programs with different start dates, rollout capacity, age-specific prioritisation year detection novel pathogen. Early...
Background Decision-makers in middle-income countries need evidence on the cost-effectiveness of COVID-19 booster doses and oral antivirals to appropriately prioritise these healthcare interventions. Methods We used a dynamic transmission model assess Fiji, Indonesia, Papua New Guinea, Timor-Leste. conducted analysis from both societal perspectives using data collated publicly available sources. developed an interactive R Shiny which allows user vary key assumptions, such as choice...
Background: Continued efforts to reduce the burden of COVID-19 require consideration additional booster doses and emerging oral antivirals.Methods: A mathematical model including age structure, vaccine coverage, prevalence comorbidities, immunity from prior infection was fitted incidence data Indonesia, Fiji, Papua New Guinea, Timor-Leste. We explored individual- population-level impact antivirals given a range eligibility criteria.Findings: Boosters had largest per dose when prioritised...
Maternal pneumococcal vaccines have been proposed as a method of protecting infants in the first few months life. In this paper, we use results from dynamic transmission model to assess cost-effectiveness maternal polysaccharide vaccine both healthcare and societal perspectives. We estimate costs delivering vaccine, averted, productivity losses avoided through prevention severe outcomes such pneumonia meningitis. Our estimates that program would cost $606 (2020 USD, 95% prediction interval...
Abstract Background Decision-makers in middle-income countries need evidence on the cost-effectiveness of COVID-19 booster doses and oral antivirals to appropriately prioritise these healthcare interventions. Methods We used a dynamic transmission model assess Fiji, Indonesia, Papua New Guinea, Timor-Leste. conducted analysis from both societal perspectives using 3% discounting for ongoing costs health benefits. developed an interactive R Shiny which allows user vary key assumptions, such as...
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Abstract Maternal pneumococcal vaccines have been proposed as a method of protecting infants in the first few months life. In this paper, we assess cost-effectiveness maternal polysaccharide vaccine using health sector perspective. We estimate costs delivering vaccine, and healthcare averted through prevention severe outcomes such pneumonia meningitis, with estimates effectiveness based on previous research. Our model that program would cost $570 per DALY (2020 USD, range $558-582), hence...
Background: COVID-19 vaccine coverage in low- and middle-income countries continues to be challenging. As supplies increase, is increasingly becoming determined by rollout capacity.Methods: We developed a deterministic compartmental model of transmission explore how age-, risk-, dose-specific prioritisation strategies can minimise severe outcomes Sierra Leone.Findings: Prioritising booster doses older adults with comorbidities could reduce the incidence disease 21% deaths 32% compared use...